Recent Analysts’ Ratings Changes for HealthEquity (HQY)

Several brokerages have updated their recommendations and price targets on shares of HealthEquity (NASDAQ: HQY) in the last few weeks:

• 6/6/2026 – HealthEquity was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/5/2026 – HealthEquity was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 6/3/2026 – HealthEquity had its price target raised by Royal Bank Of Canada from $100.00 to $108.00. They now have an “outperform” rating on the stock.
• 6/1/2026 – HealthEquity was given a new $111.00 price target by Wells Fargo & Company.
• 6/1/2026 – HealthEquity had its “market outperform” rating reaffirmed by Citigroup Inc..
• 6/1/2026 – HealthEquity had its price target raised by Citizens Jmp from $110.00 to $111.00. They now have a “market outperform” rating on the stock.
• 5/29/2026 – HealthEquity had its price target raised by Royal Bank Of Canada from $100.00 to $108.00. They now have an “outperform” rating on the stock.
• 5/26/2026 – HealthEquity had its “overweight” rating reaffirmed by KeyCorp.
• 5/22/2026 – HealthEquity had its “outperform” rating reaffirmed by Barrington Research. They now have a $110.00 price target on the stock.
• 5/9/2026 – HealthEquity was downgraded by Wall Street Zen from “buy” to “hold”.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president owned 59,113 shares in the company, valued at approximately $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the transaction, the director owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 13,081 shares of company stock worth $1,193,000. 1.60% of the stock is currently owned by company insiders.

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.